袖状胃切除术一年后肥胖症青少年的皮质醇/可的松比率。

IF 1.3 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Metabolic syndrome and related disorders Pub Date : 2024-11-01 Epub Date: 2024-08-20 DOI:10.1089/met.2024.0106
Ana Paola Lopez Lopez, Meghan Lauze, Miriam A Bredella, Madhusmita Misra, Vibha Singhal
{"title":"袖状胃切除术一年后肥胖症青少年的皮质醇/可的松比率。","authors":"Ana Paola Lopez Lopez, Meghan Lauze, Miriam A Bredella, Madhusmita Misra, Vibha Singhal","doi":"10.1089/met.2024.0106","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Glucocorticoid metabolites are associated with body composition measures and are altered with weight status. Metabolic and bariatric surgery (MBS) results in significant changes in weight and body composition. However, MBS effects on glucocorticoid metabolites are unknown. <b><i>Objective:</i></b> To evaluate (i) changes in the cortisol/cortisone ratio in youth with obesity 12 months after sleeve gastrectomy (SG) compared with nonsurgical controls with obesity (NS), and (ii) associations of these changes with body composition changes. <b><i>Methods:</i></b> A total of 38 participants 13-25 years old with obesity (29 female) were followed for 12 months. Half underwent SG, and the other half were followed with routine care (nonsurgical, NS). Fasting blood was assessed for cortisol and cortisone using liquid chromatography-mass spectroscopy as part of metabolomic analysis, and the cortisol/cortisone ratio was calculated. A single-slice MRI of the abdomen was performed to assess subcutaneous and visceral adipose tissue (SAT, VAT<u>)</u>. Hepatic steatosis was assessed by computed tomography (CT). <b><i>Results:</i></b> SG did not differ from NS for baseline clinical characteristics, other than the mean age (SG 18.0 ± 0.46 vs. NS 16.6 ± 0.50 years, <i>P</i> = 0.041), BMI (BMI, 47.23 ± 1.5 vs. 41.32 ± 1.1 kg/m<sup>2</sup>, <i>P</i> = 0.003) weight and VAT, which were higher in SG. Significant reductions were noted over 12 months in BMI, BMI z-score, VAT, and SAT within the SG versus NS groups (<i>P</i> ≤ 0.001). Over 12 months, groups did not differ for changes in cortisol/cortisone ratio after controlling for age at baseline (<i>P</i> = 0.293). The ratio trended to decrease within the SG group [-1.40 (-5.08, 0.06), <i>P</i> = 0.080], particularly among those that had completed puberty (<i>P</i> = 0.048). No associations were found between changes in the cortisol/cortisone ratio and changes in body composition. <b><i>Conclusions:</i></b> The cortisol/cortisone ratio trended to decrease 12 months following SG. However, no associations were found between changes in the cortisol/cortisone ratio and changes in body composition. Studies with larger numbers of participants are necessary to confirm these findings.</p>","PeriodicalId":18405,"journal":{"name":"Metabolic syndrome and related disorders","volume":" ","pages":"646-650"},"PeriodicalIF":1.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cortisol/Cortisone Ratio in Youth with Obesity One Year Following Sleeve Gastrectomy.\",\"authors\":\"Ana Paola Lopez Lopez, Meghan Lauze, Miriam A Bredella, Madhusmita Misra, Vibha Singhal\",\"doi\":\"10.1089/met.2024.0106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Glucocorticoid metabolites are associated with body composition measures and are altered with weight status. Metabolic and bariatric surgery (MBS) results in significant changes in weight and body composition. However, MBS effects on glucocorticoid metabolites are unknown. <b><i>Objective:</i></b> To evaluate (i) changes in the cortisol/cortisone ratio in youth with obesity 12 months after sleeve gastrectomy (SG) compared with nonsurgical controls with obesity (NS), and (ii) associations of these changes with body composition changes. <b><i>Methods:</i></b> A total of 38 participants 13-25 years old with obesity (29 female) were followed for 12 months. Half underwent SG, and the other half were followed with routine care (nonsurgical, NS). Fasting blood was assessed for cortisol and cortisone using liquid chromatography-mass spectroscopy as part of metabolomic analysis, and the cortisol/cortisone ratio was calculated. A single-slice MRI of the abdomen was performed to assess subcutaneous and visceral adipose tissue (SAT, VAT<u>)</u>. Hepatic steatosis was assessed by computed tomography (CT). <b><i>Results:</i></b> SG did not differ from NS for baseline clinical characteristics, other than the mean age (SG 18.0 ± 0.46 vs. NS 16.6 ± 0.50 years, <i>P</i> = 0.041), BMI (BMI, 47.23 ± 1.5 vs. 41.32 ± 1.1 kg/m<sup>2</sup>, <i>P</i> = 0.003) weight and VAT, which were higher in SG. Significant reductions were noted over 12 months in BMI, BMI z-score, VAT, and SAT within the SG versus NS groups (<i>P</i> ≤ 0.001). Over 12 months, groups did not differ for changes in cortisol/cortisone ratio after controlling for age at baseline (<i>P</i> = 0.293). The ratio trended to decrease within the SG group [-1.40 (-5.08, 0.06), <i>P</i> = 0.080], particularly among those that had completed puberty (<i>P</i> = 0.048). No associations were found between changes in the cortisol/cortisone ratio and changes in body composition. <b><i>Conclusions:</i></b> The cortisol/cortisone ratio trended to decrease 12 months following SG. However, no associations were found between changes in the cortisol/cortisone ratio and changes in body composition. Studies with larger numbers of participants are necessary to confirm these findings.</p>\",\"PeriodicalId\":18405,\"journal\":{\"name\":\"Metabolic syndrome and related disorders\",\"volume\":\" \",\"pages\":\"646-650\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Metabolic syndrome and related disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/met.2024.0106\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic syndrome and related disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/met.2024.0106","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:糖皮质激素代谢物与身体成分测量相关,并随体重状况而改变。代谢和减肥手术(MBS)会导致体重和身体成分发生显著变化。然而,代谢与减肥手术对糖皮质激素代谢物的影响尚不清楚。研究目的评估(i)袖带胃切除术(SG)后 12 个月与非手术肥胖对照组(NS)相比,肥胖青年体内皮质醇/可的松比率的变化,以及(ii)这些变化与身体成分变化的关联。研究方法对 38 名 13-25 岁的肥胖症患者(29 名女性)进行为期 12 个月的随访。一半人接受了 SG,另一半人接受了常规护理(非手术,NS)。作为代谢组学分析的一部分,采用液相色谱-质谱法对空腹血液中的皮质醇和可的松进行评估,并计算皮质醇/可的松比率。对腹部进行单片核磁共振成像,以评估皮下和内脏脂肪组织(SAT、VAT)。肝脏脂肪变性通过计算机断层扫描(CT)进行评估。结果显示除了平均年龄(SG 18.0 ± 0.46 岁 vs. NS 16.6 ± 0.50 岁,P = 0.041)、体重指数(BMI,47.23 ± 1.5 vs. 41.32 ± 1.1 kg/m2,P = 0.003)和脂肪体积(VAT)高于 SG 外,SG 的基线临床特征与 NS 无差异。在 12 个月内,SG 组与 NS 组相比,BMI、BMI z-score、VAT 和 SAT 均显著下降(P ≤ 0.001)。12 个月内,在控制基线年龄后,各组在皮质醇/可的松比率的变化上没有差异(P = 0.293)。SG组的皮质醇/可的松比率呈下降趋势[-1.40 (-5.08, 0.06),P = 0.080],尤其是在完成青春期发育的人群中(P = 0.048)。皮质醇/可的松比率的变化与身体成分的变化之间没有关联。结论皮质醇/可的松比率在 SG 后 12 个月呈下降趋势。但是,皮质醇/可的松比率的变化与身体成分的变化之间没有关联。有必要对更多参与者进行研究,以证实这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cortisol/Cortisone Ratio in Youth with Obesity One Year Following Sleeve Gastrectomy.

Background: Glucocorticoid metabolites are associated with body composition measures and are altered with weight status. Metabolic and bariatric surgery (MBS) results in significant changes in weight and body composition. However, MBS effects on glucocorticoid metabolites are unknown. Objective: To evaluate (i) changes in the cortisol/cortisone ratio in youth with obesity 12 months after sleeve gastrectomy (SG) compared with nonsurgical controls with obesity (NS), and (ii) associations of these changes with body composition changes. Methods: A total of 38 participants 13-25 years old with obesity (29 female) were followed for 12 months. Half underwent SG, and the other half were followed with routine care (nonsurgical, NS). Fasting blood was assessed for cortisol and cortisone using liquid chromatography-mass spectroscopy as part of metabolomic analysis, and the cortisol/cortisone ratio was calculated. A single-slice MRI of the abdomen was performed to assess subcutaneous and visceral adipose tissue (SAT, VAT). Hepatic steatosis was assessed by computed tomography (CT). Results: SG did not differ from NS for baseline clinical characteristics, other than the mean age (SG 18.0 ± 0.46 vs. NS 16.6 ± 0.50 years, P = 0.041), BMI (BMI, 47.23 ± 1.5 vs. 41.32 ± 1.1 kg/m2, P = 0.003) weight and VAT, which were higher in SG. Significant reductions were noted over 12 months in BMI, BMI z-score, VAT, and SAT within the SG versus NS groups (P ≤ 0.001). Over 12 months, groups did not differ for changes in cortisol/cortisone ratio after controlling for age at baseline (P = 0.293). The ratio trended to decrease within the SG group [-1.40 (-5.08, 0.06), P = 0.080], particularly among those that had completed puberty (P = 0.048). No associations were found between changes in the cortisol/cortisone ratio and changes in body composition. Conclusions: The cortisol/cortisone ratio trended to decrease 12 months following SG. However, no associations were found between changes in the cortisol/cortisone ratio and changes in body composition. Studies with larger numbers of participants are necessary to confirm these findings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Metabolic syndrome and related disorders
Metabolic syndrome and related disorders MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
3.40
自引率
0.00%
发文量
74
审稿时长
6-12 weeks
期刊介绍: Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma. Metabolic Syndrome and Related Disorders coverage includes: -Insulin resistance- Central obesity- Glucose intolerance- Dyslipidemia with elevated triglycerides- Low HDL-cholesterol- Microalbuminuria- Predominance of small dense LDL-cholesterol particles- Hypertension- Endothelial dysfunction- Oxidative stress- Inflammation- Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信